Review article · 2020 · Open access
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
Alzheimer s Research & Therapy, 12(1), 20 · Published 28 February 2020 · DOI 10.1186/s13195-020-00586-6
In brief
“Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg” is a 2020 review article by Pawel Obrocki and 14 co-authors, published in Alzheimer s Research & Therapy. OpenAlex counts 56 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Alzheimer s Research & Therapy.
- Citations
- 56
- Most cited in
- 2022 (19)
- Field-weighted impact
- 1.13
- References
- 129
- Authors
- 15
Abstract
Until relatively recently, a diagnosis of probable Alzheimer's disease (AD) and other neurodegenerative disorders was principally based on clinical presentation, with post-mortem examination remaining a gold standard for disease confirmation. This is in sharp contrast to other areas of medicine, where fluid biomarkers, such as troponin levels in myocardial infarction, form an integral part of the diagnostic and treatment criteria. There is a pressing need for such quantifiable and easily accessible tools in neurodegenerative diseases.In this paper, based on lectures given at the 2019 Biomarkers in Neurodegenerative Diseases Course, we provide an overview of a range of cerebrospinal fluid (CSF) and blood biomarkers in neurodegenerative disorders, including the 'core' AD biomarkers amyloid β (Aβ) and tau, as well as other disease-specific and general markers of neuroaxonal injury. We then highlight the main challenges in the field, and how those could be overcome with the aid of new methodological advances, such as assay automation, mass spectrometry and ultrasensitive immunoassays.As we hopefully move towards an era of disease-modifying treatments, reliable biomarkers will be essential to increase diagnostic accuracy, allow for earlier diagnosis, better participant selection and disease activity and treatment effect monitoring.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Obrocki, P., Khatun, A., Ness, D., Senkevich, K. A., Hanrieder, J., Capraro, F., Mattsson, N., Andréasson, U., Portelius, E., Ashton, N. J., Blennow, K., Schöll, M., Paterson, R. W., Schott, J. M., & Zetterberg, H. (2020). Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg. Alzheimer s Research & Therapy, 12(1), 20. https://doi.org/10.1186/s13195-020-00586-6
MLA 9
Obrocki, Pawel, et al. “Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg.” Alzheimer s Research & Therapy, vol. 12, no. 1, 2020, p. 20. https://doi.org/10.1186/s13195-020-00586-6.
Chicago
Obrocki, Pawel, Ayesha Khatun, Deborah Ness, Konstantin A. Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, et al. 2020. “Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg.” Alzheimer s Research & Therapy 12 (1): 20. https://doi.org/10.1186/s13195-020-00586-6.
Harvard
Obrocki, P. et al. (2020) ‘Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg’, Alzheimer s Research & Therapy, 12(1), p. 20. doi:10.1186/s13195-020-00586-6.
IEEE
P. Obrocki et al., “Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg,” Alzheimer s Research & Therapy, vol. 12, no. 1, p. 20, 2020, doi: 10.1186/s13195-020-00586-6.
BibTeX
@article{obrocki2020perspectives,
title = {{Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg}},
author = {Obrocki, Pawel and Khatun, Ayesha and Ness, Deborah and Senkevich, Konstantin A. and Hanrieder, Jörg and Capraro, Federica and Mattsson, Niklas and Andréasson, Ulf and Portelius, Erik and Ashton, Nicholas James and Blennow, Kaj and Schöll, Michael and Paterson, Ross W. and Schott, Jonathan M. and Zetterberg, Henrik},
journal = {Alzheimer s Research \& Therapy},
year = {2020},
volume = {12},
number = {1},
pages = {20},
doi = {10.1186/s13195-020-00586-6},
url = {https://doi.org/10.1186/s13195-020-00586-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 1 | |
| 2020 | 1 | |
| 2021 | 8 | |
| 2022 | 19 | |
| 2023 | 10 | |
| 2024 | 8 | |
| 2025 | 5 | |
| 2026 | 4 |
Its field-weighted citation impact is 1.13: it has been cited 1.13 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- fluid biomarkers
- neurodegenerative diseases
- Alzheimer's disease
- cerebrospinal fluid biomarkers
- blood biomarkers
- amyloid-beta
- tau protein
- neuroaxonal damage
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Obrocki, P., Khatun, A., Ness, D., Senkevich, K. A., Hanrieder, J., Capraro, F., Mattsson, N., Andréasson, U., Portelius, E., Ashton, N. J., Blennow, K., Schöll, M., Paterson, R. W., Schott, J. M., & Zetterberg, H. (2020). Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg. Alzheimer s Research & Therapy, 12(1), 20. https://doi.org/10.1186/s13195-020-00586-6
How many times has this paper been cited?
56 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Alzheimer s Research & Therapy: sign in and open the PDF from this page.
Who wrote this paper?
Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin A. Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andréasson, Erik Portelius, Nicholas James Ashton, Kaj Blennow, Michael Schöll and 3 more.
What is the DOI of this paper?
10.1186/s13195-020-00586-6, permanently at https://doi.org/10.1186/s13195-020-00586-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.